-
digital.ahrq.gov/sites/default/files/docs/citation/u18hs026849-dorr-final-report-2022.pdf
January 01, 2022 - can be narrow; a
large blood pressure trial, the SPRINT study, showed a 25% relative reduction in cardiovascular … management while also helping their care teams to obtain a more
complete understanding of the patient’s cardiovascular … Gamified applications for secondary prevention in patients
with high cardiovascular disease risk: A
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/QZ-N4vDvgZSsghretDokg7
March 01, 2014 - control groups (ischemic
heart disease [8.7% and 9.0%, respectively], stroke [2.7%
for both], other cardiovascular … high-risk approach using a validated multifactorial risk cal-
culator that considers family history, cardiovascular … Takagi H, Niwa M, Mizuno Y, Goto SN, Umemoto T; All-Literature
Investigation of Cardiovascular Evidence
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/teeHcmNgvNBSj4-E9SN5QK
February 01, 2005 - Potential confounding of screening trial results
may also have occurred because of improved
management of cardiovascular … risk for AAA depends
on a variety of factors, such as age, sex, smoking
history, family history, and cardiovascular … Effect of antihypertensive drug
treatment on cardiovascular outcomes in women and
men.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/exVc75LHoUdnqjY6wYxzGV
June 01, 2003 - A recent article in
the British Medical Journal questioned whether the
cardiovascular and mental health … exposure might outweigh its harmful effects.84
The authors hypothesized that seasonal patterns
in cardiovascular … mortality and in cardiovascular
risk factors may be related to sun exposure.
-
hcup-us.ahrq.gov/db/tools/HCUP_Formats.TXT
December 28, 2023 - procedures on vessels other than head and neck"
62 = " 62: Other diagnostic cardiovascular … procedures"
63 = " 63: Other non-OR therapeutic cardiovascular procedures" … 34 - 42 = " 6: Proc on Respiratory System"
43 - 63 = " 7: Proc on Cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/skin-cancer-counseling-2003
October 06, 2003 - A recent article in the British Medical Journal questioned whether the cardiovascular and mental health … exposure might outweigh its harmful effects. 84 The authors hypothesized that seasonal patterns in cardiovascular … mortality and in cardiovascular risk factors may be related to sun exposure.
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2019_IP_MaskedStats.PDF
January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 4,974 0.10
245: AICD GENERATOR PROCEDURES 712 0.02
246: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W MCC 6,913 0.15
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 4,592 0.10
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 1,156 0.02
273: PERCUTANEOUS INTRACARDIAC PROCEDURES W MCC … PROCEDURES W MCC 6,914 0.15
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 4,591 0.10
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 1,156 0.02
273: PERCUTANEOUS INTRACARDIAC PROCEDURES W MCC
-
www.ahrq.gov/sites/default/files/2024-01/aparasu-report.pdf
January 01, 2024 - The medications included use of cardiovascular
agents and psychotropic agents (30 days before the event … cerebrovascular events, osteoarthritis, osteoporosis, and
rheumatoid arthritis; co-medications like cardiovascular … Association of anticholinergic drugs with hospitalization and
mortality among older cardiovascular patients … Total anticholinergic burden and risk of mortality and cardiovascular disease
over 10 years in 21,636
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-evaluation-summary-report-p233201500023I.pdf
March 23, 2022 - Medicaid Services
CPG-on-FHIR Clinical Practice Guidelines on FHIR
CQL Clinical Quality Language
CVD Cardiovascular … TISTA Science and Technology Corporation 1 (1.4)
Clinical Topic Areas
Primary Care 15 (20.3)
Cardiovascular … artifact
MITRE March -
September
2017
AllianceChicago Statin Use for the Primary
Prevention of
Cardiovascular … Counseling to
Promote a Healthful Diet
and Physical Activity for
CVD Prevention in Adults
with Cardiovascular
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core_Weighted.PDF
January 01, 2017 - PERC CARDIOVASC PROC W DRUG-ELUTING STENT W MCC OR 4+ VESSELS/STENTS 79,400 0.22%
246: PERCUTANEOUS CARDIOVASCULAR … PERC CARDIOVASC PROC W NON-DRUG-ELUTING STENT W MCC OR 4+ VES/STENTS 8,100 0.02%
248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 33,870 0.09%
270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 44,215 0.12%
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 37,220 0.10%
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 16,305 0.05%
273: PERCUTANEOUS INTRACARDIAC PROCEDURES W
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_V2.PDF
January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 6,005 0.08%
245: AICD GENERATOR PROCEDURES 994 0.01%
246: PERCUTANEOUS CARDIOVASCULAR … 24,585 0.35%
247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 54,474 0.77%
248: PERCUTANEOUS CARDIOVASCULAR … : AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 6,624 0.09%
270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 9,861 0.14%
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 8,064 0.11%
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 3,207 0.05%
273: PERCUTANEOUS INTRACARDIAC PROCEDURES W
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
June 26, 2018 - Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the … use, rheumatoid arthritis, alcohol use, hormone replacement therapy, i asthma, endrocrine disease, cardiovascular … 1.01 (95% CI, 0.98-1.05); 13 trials, n = 20,485 d
No statistically significant differences for cardiovascular … discontinuations, serious adverse events, and upper GI tract events; inconsistent and imprecise for cardiovascular … bisphosphonates for discontinuation, serious adverse events, and upper gastrointestinal events; insufficient for cardiovascular
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Core_Weighted_V2.PDF
January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 31,544 0.09%
245: AICD GENERATOR PROCEDURES 5,171 0.01%
246: PERCUTANEOUS CARDIOVASCULAR … 123,463 0.35%
247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 281,990 0.80%
248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION
BALLOON W/O MCC
34,999 0.10%
270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 46,432 0.13%
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 40,801 0.12%
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 16,462 0.05%
273: PERCUTANEOUS INTRACARDIAC PROCEDURES W
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_CORE_V2.PDF
January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 17,878 0.10%
245: AICD GENERATOR PROCEDURES 2,913 0.02%
246: PERCUTANEOUS CARDIOVASCULAR … 68,419 0.38%
247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 155,954 0.86%
248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION
BALLOON W/O MCC
18,694 0.10%
270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 24,937 0.14%
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 22,044 0.12%
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 8,870 0.05%
273: PERCUTANEOUS INTRACARDIAC PROCEDURES W
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
January 01, 2018 - PACEMAKER IMPLANT W/O CC/MCC 18,042 0.10%
245: AICD GENERATOR PROCEDURES 3,288 0.02%
246: PERCUTANEOUS CARDIOVASCULAR … 62,623 0.35%
247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 150,877 0.85%
248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION
BALLOON W/O MCC
18,641 0.11%
270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 22,693 0.13%
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 20,637 0.12%
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 8,400 0.05%
273: PERCUTANEOUS INTRACARDIAC PROCEDURES W
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 102 0.00%
245: AICD GENERATOR PROCEDURES 86 0.00%
246: PERCUTANEOUS CARDIOVASCULAR … MCC OR 22 0.00%
247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 18 0.00%
248: PERCUTANEOUS CARDIOVASCULAR … 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 629 0.02%
270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 2,060 0.07%
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 888 0.03%
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 357 0.01%
273: PERCUTANEOUS INTRACARDIAC PROCEDURES W MCC
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
April 15, 2013 - These trials also provide estimates of harm, including thromboembolic events, cardiovascular disease … Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. … Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women … Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the … Year-by-year analysis of cardiovascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
April 01, 2022 - mechanism vs. opioid
agonist and mortality,
falls/fracture,
hospitalization for
adverse event, or
cardiovascular … studies 1 retrospective cohort study
(n=77,697) found tramadol
associated with decreased risk
of cardiovascular … hospitalizations compared with opioid
agonists.6 Tramadol was associated with slightly decreased risk of cardiovascular … harms, falls, fractures, motor vehicle accidents,
B-2
endocrinological harms, infections, cardiovascular … (gastrointestinal, somnolence, pruritus, dizziness,
headache, fracture, motor vehicle accidents,
cardiovascular
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Core.PDF
January 01, 2011 - 106: CORONARY BYPASS W PTCA 1,306 0.02%
108: OTHER CARDIOTHORACIC PROCEDURES 5,482 0.07%
110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 22,618 0.28%
111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 5,532 0.07%
113: AMPUTATION … PERCUTANEOUS CARDIOVASC PROC W NON-DRUG-ELUTING STENT W/O MAJ CV DX 6,201 0.08%
557: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX 45,785 0.57%
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 3,903 0.05%
63: Other non-OR therapeutic cardiovascular procedures 14,615 0.18%
64: Bone
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core.PDF
January 01, 2009 - PROCEDURES W CC 3,426 0.10%
111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 1,091 0.03%
113: AMPUTATION … 18, 2011 38
Frequency Distribution for DRG24
DRG24 Frequency
Percent
of Total
557: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W
MAJOR CV DX
<= 10 *.**%
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … 0.00%
61: Other OR procedures on vessels other than head and neck 8,588 0.25%
62: Other diagnostic cardiovascular … procedures 543 0.02%
63: Other non-OR therapeutic cardiovascular procedures 996 0.03%
64: Bone marrow